Search research articles
Contact Us
Filters
Showing results (141-150 of 231) with videos related to
Page
of 24
Sort By:
Cancer Immunology, Immunotherapy : CII
|
July 2, 2013
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis
Bridget Charbonneau, Alice H Wang, Matthew J Maurer, et al.
American Journal of Hematology
|
September 18, 2014
Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphoma
Thomas E Witzig, Matthew J Maurer, Thomas M Habermann, et al.
Blood
|
March 6, 2012
Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study
Myron S Czuczman, Luis Fayad, Vincent Delwail, et al.
Clinical Epidemiology
|
December 10, 2019
Pretreatment Hemoglobin Adds Prognostic Information To The NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Containing Chemotherapy
Michael R Clausen, Matthew J Maurer, Sinna Pilgaard Ulrichsen, et al.
Blood Advances
|
October 18, 2021
Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes
Alessia Castellino, Yucai Wang, Melissa C Larson, et al.
Blood Advances
|
July 18, 2022
Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study
Aung M Tun, Arushi Khurana, Raphael Mwangi, et al.
Blood Cancer Journal
|
November 13, 2023
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study
Allison M Bock, Jennifer J Gile, Melissa C Larson, et al.
Blood Advances
|
August 16, 2022
Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma
Gilles Salles, Stephen J Schuster, Martin Dreyling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2010
Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma
Matthew T Drake, Matthew J Maurer, Brian K Link, et al.
Blood Advances
|
September 25, 2024
Transformation in marginal zone lymphoma: results from a prospective cohort and a meta-analysis of the literature
Côme Bommier, Brian K Link, Brianna J Gysbers, et al.
Page
of 24
Search research articles
Search
Showing results (141-150 of 231) with videos related to
Sort By:
Page
of 24
Cancer Immunology, Immunotherapy : CII
|
July 2, 2013
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis
Bridget Charbonneau, Alice H Wang, Matthew J Maurer, et al.
American Journal of Hematology
|
September 18, 2014
Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphoma
Thomas E Witzig, Matthew J Maurer, Thomas M Habermann, et al.
Blood
|
March 6, 2012
Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study
Myron S Czuczman, Luis Fayad, Vincent Delwail, et al.
Clinical Epidemiology
|
December 10, 2019
Pretreatment Hemoglobin Adds Prognostic Information To The NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Containing Chemotherapy
Michael R Clausen, Matthew J Maurer, Sinna Pilgaard Ulrichsen, et al.
Blood Advances
|
October 18, 2021
Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes
Alessia Castellino, Yucai Wang, Melissa C Larson, et al.
Blood Advances
|
July 18, 2022
Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study
Aung M Tun, Arushi Khurana, Raphael Mwangi, et al.
Blood Cancer Journal
|
November 13, 2023
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study
Allison M Bock, Jennifer J Gile, Melissa C Larson, et al.
Blood Advances
|
August 16, 2022
Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma
Gilles Salles, Stephen J Schuster, Martin Dreyling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2010
Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma
Matthew T Drake, Matthew J Maurer, Brian K Link, et al.
Blood Advances
|
September 25, 2024
Transformation in marginal zone lymphoma: results from a prospective cohort and a meta-analysis of the literature
Côme Bommier, Brian K Link, Brianna J Gysbers, et al.
Page
of 24